PainQx
New York
About PainQx
PainQx is a diagnostic/software company that has developed a next generation approach to objectively measure pain in humans. The PainQx platform achieves this by assessing neural activity from a patient’s brain and processing and decoding the data through proprietary algorithms. The output is a scaled pain and neurological side effects biomarker that is directly correlated to a patient’s pain state. The PainQx system is currently being used as a clinical assessment tool by companies using pain as a primary or secondary clinical end point to measure their drug’s and/or device’s efficacy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.8M
- Funding stage: Seed
- Last round: Grant (Jun 2021)
- Website: painqx.com
- Phone: 617-981-7753
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Health Care, Health Diagnostics, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/painqx-66188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.